Zuoxiang Wang

Zuoxiang Wang

Auto-generated profile, based on publicly available information

Zuoxiang Wang

Affiliation Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 August 2025 in Journal of the American Heart Association
Verified
Journal Article
Open access
ZWZuoxiang Wang
Zuoxiang Wang
JLJunxing Lv
Junxing Lv
XQXifeng Qian
Xifeng Qian
ZLZiang Li
Ziang Li
ZYZheng Yin
Zheng Yin
YWYong-Jian Wu
Yong-Jian Wu
Background: Accumulating evidence indicates that degenerative valvular heart disease (VHD) and rheumatoid arthritis (RA) share overlapping risk factors and intersecting inflammatory processes; however, their interrelationship remains insufficiently explored. Methods: Among 492 745 UK Biobank participants without VHD at baseline, Cox proportional hazards models were conducted to assess the association between prevalent RA and new‐onset degenerative VHD, with sequential adjustments for demographic factors, lifestyle variables, and comorbidities. The end points of degenerative VHD in this study included 8 subtypes: aortic stenosis, aortic regurgitation, mitral stenosis, mitral regurgitation, tricuspid stenosis, tricuspid regurgitation, pulmonary stenosis, and pulmonary regurgitation. Results: Among participants with RA (n=6673), 359 cases of degenerative VHD were recorded over a median follow‐up of 13.71 (interquartile range, 12.71–14.55) years, compared with 13 518 cases in those without RA (n=486 072) over a median follow‐up of 13.78 (interquartile range, 12.96–14.51) years. After full adjustment, RA was significantly associated with a higher risk of 3 types of new‐onset degenerative VHD: aortic stenosis (hazard ratio [HR], 1.64 [95% CI, 1.40–1.92]), aortic regurgitation (HR, 1.69 [95% CI, 1.34–2.13]), and mitral regurgitation (HR, 1.54 [95% CI, 1.32–1.81]), while no significant association was observed between RA and other degenerative VHD subtypes. Moreover, sex subgroup analyses revealed an interaction between sex and RA in the occurrence of aortic stenosis ( P for interaction=0.02) and mitral regurgitation ( P for interaction=0.04), indicating a higher risk in women. Conclusions: The presence of RA indicated an elevated risk of new‐onset degenerative aortic stenosis, aortic regurgitation, and mitral regurgitation, which required further investigation and better disease management.

10 June 2005 in Acta Crystallographica Section E Structure Reports Online
Verified
Journal Article
Open access
PDF file
ZWZuo-Xiang Wang
Zuo-Xiang Wang
YLYan Lan
Yan Lan
LYLu-Tong Yuan
Lu-Tong Yuan
CLChun-Yi Liu
Chun-Yi Liu

13 November 2024 in European Heart Journal - Quality of Care and Clinical Outcomes
Verified
Journal Article
Closed access
PDF file
ZWZuoxiang Wang
Zuoxiang Wang
JLJunxing Lv
Junxing Lv
SZSheng Zhao
Sheng Zhao
ZYZheng Yin
Zheng Yin
WSWence Shi
Wence Shi
YWYong-Jian Wu
Yong-Jian Wu
Background: Recent evidence indicates that degenerative valvular heart disease (VHD) and psoriasis share overlapping risk factors and simultaneous presence of inflammation, yet this relationship has not been thoroughly explored. Methods and results: Drawing on the prospective cohort data from the UK Biobank, baseline information on psoriasis and the incidence of eight specific types of degenerative VHD—aortic stenosis (AS), aortic regurgitation, mitral stenosis, mitral regurgitation, tricuspid stenosis, tricuspid regurgitation, pulmonary stenosis, and pulmonary regurgitation—during the follow-up period were recorded. Cox proportional hazards models were conducted to estimate the association between psoriasis and the risk of degenerative VHD, adjusted for demographic indicators, lifestyle factors, comorbidities, and medication. A total of 494 510 participants were included in the study. Among the participants without psoriasis, 13 672 events of degenerative VHD were observed during a median follow-up of 13.78 years, yielding an incidence rate of 2.14 per 1000 person-years. In contrast, in the psoriasis group (n = 10 917), 422 events of degenerative VHD were reported during a median follow-up of 13.70 years, corresponding to an incidence rate of 2.93 per 1000 person-years. After fully adjusting, participants with psoriasis had a significantly increased risk of AS (hazard ratio, 1.24; 95% confidence interval, 1.07–1.43), yet no significant associations were observed between psoriasis and the risk of other degenerative valve diseases. In sex subgroup analyses, there was an interaction between sex and psoriasis in the occurrence of AS (P for interaction = 0.039), suggesting a high risk in women. Conclusions: Psoriasis was significantly associated with the risk of new-onset AS and may be more distinct in females, while no significant associations were observed between psoriasis and the risk of developing other degenerative valve diseases.

1 March 2015 in Russian Journal of General Chemistry
Verified
Journal Article
Closed access
PDF file
NWNing Wang
Ning Wang
JSJun-Feng Sheng
Jun-Feng Sheng
FSFei Song
Fei Song
YTYu-Zhu Tong
Yu-Zhu Tong
ZWZuo-Xiang Wang
Zuo-Xiang Wang

7 August 2026 in PLOS Digital Health
Verified
Journal Article
Open access
PDF file
ZWZuoxiang Wang
Zuoxiang Wang
ZYZheng Yin
Zheng Yin
JLJunxing Lv
Junxing Lv
SZSheng Zhao
Sheng Zhao
ZBZhengqing Ba
Zhengqing Ba
YYYuejin Yang
Yuejin Yang
Patients with diabetes constitute a substantial proportion of those with acute myocardial infarction (AMI) and exhibit distinct pathophysiological characteristics. However, existing guideline-recommended traditional and generic risk prediction models show limited performance in this specific population. Based on the China Acute Myocardial Infarction (CAMI) registry, 6,091 diabetic patients with AMI were enrolled and randomly divided into training and test sets (8:2). A comprehensive set of 62 multidimensional candidate features was extracted, and three feature selection strategies were applied to develop 12 machine learning models across six algorithm categories. All models underwent hyperparameter tuning via five-fold cross-validation in the training set, with the optimal combination selected according to the area under the receiver operating characteristic curve (AUROC). Two post-hoc ensemble strategies—stacking and probability averaging—were then employed to explore various combinations of top-performing models from different algorithm categories. Across six algorithm categories, the predictive models developed using 11 features selected by Elastic Net had the optimal performance. After evaluating various fusion strategies, the ensembled GLM + TabNet model was ultimately selected as the CAMI-DM model 2.0, achieving an AUROC of 0.875 in the test set. To balance the predictive performance and model simplicity, the CAMI-DM model 1.0 adopted a linear framework and was developed using five features from consensus feature selection Strategy, with an AUROC of 0.821 in the test set. Comparative analyses revealed that the CAMI-DM 2.0 outperformed CAMI-DM 1.0 in terms of discrimination, accuracy, calibration, and clinical net benefit. Furthermore, CAMI-DM 1.0, with its simplified structure, still outperformed the GRACE score in the overall predictive performance and generalizability. This study focused on the specific population of AMI patients with diabetes, and for the first time developed two dedicated models to predict in-hospital mortality risk.

19 August 2025 in Heart
Verified
Journal Article
Closed access
PDF file
ZWZuoxiang Wang
Zuoxiang Wang
XQXifeng Qian
Xifeng Qian
JLJunxing Lv
Junxing Lv
ZLZiang Li
Ziang Li
ZYZheng Yin
Zheng Yin
YWYong-Jian Wu
Yong-Jian Wu
Background Asthma has been associated with the development and progression of various cardiovascular diseases but its relationship with degenerative valvular heart disease (VHD) remains unclear. This study investigated the association between asthma and incident degenerative VHD, including aortic stenosis (AS), aortic regurgitation (AR), mitral regurgitation (MR) and pulmonary regurgitation (PR). Methods We analysed 483 735 participants from the UK Biobank (median age 56.5 years; 45.2% male) who were free of VHD at baseline. Asthma status was self-reported at recruitment. Incident VHD was ascertained through hospital admission and mortality records using International Classification of Diseases, Tenth Revision codes. Cox proportional hazards models were used to estimate HRs and 95% CIs for each VHD subtype, adjusting for demographic, lifestyle and clinical covariates. Sensitivity analyses accounted for asthma medications, duration of asthma and competing risks. Results Over a median follow-up of 13.8 years, 5388 participants developed AS, 2650 AR, 6088 MR and 821 PR. Asthma was associated with increased risk of AS (HR 1.31; 95% CI 1.21 to 1.41), AR (HR 1.24; 95% CI 1.11 to 1.39), MR (HR 1.19; 95% CI 1.10 to 1.28) and PR (HR 1.34; 95% CI 1.10 to 1.62). The association with AR was attenuated after adjusting for asthma medications (HR 1.12; 95% CI 0.97 to 1.30). Results were robust across multiple sensitivity analyses, including adjustment for asthma duration and exclusion of participants with pre-existing cardiovascular disease. Conclusions Asthma is independently associated with a modestly increased risk of several degenerative VHDs, particularly aortic and mitral valve diseases. These findings suggest a potential shared inflammatory pathway and highlight the need for heightened cardiovascular surveillance in individuals with asthma.